Mark Enyedy

(Mr. Mark Enyedy J.D.)

Currently holds positions in LogicBio Therapeutics Inc, Akebia Therapeutics Inc and ImmunoGen Inc

Positions
Position Company Period
Director LogicBio Therapeutics Inc March 17, 2020 -
Independent Director Akebia Therapeutics Inc Dec. 12, 2018 -
President, Chief Executive Officer, Director ImmunoGen Inc May 16, 2016 -
Independent Director Keryx Biopharmaceuticals Inc Sept. 11, 2017 - Dec. 12, 2018
Independent Director Fate Therapeutics Inc July 1, 2012 - May 2, 2018
Director Proteostasis Therapeutics Inc June 30, 2014 - Jan. 1, 2015
Chief Executive Officer, Director Proteostasis Therapeutics Inc None -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2024-02-06 2024-02-05
US ImmunoGen Inc (IMGN)
PS Planned sale
20,107 -3.3%
29.28
588,733 USD
20,107 -3.3% 29.28 588,733 USD
2023-08-04 2023-08-04
US ImmunoGen Inc (IMGN)
S Sale
992,397 -64.2%
16.96
16,831,053 USD
992,397 -64.2% 16.96 16,831,053 USD
2023-08-04 2023-08-03
US ImmunoGen Inc (IMGN)
S Sale
1,020,000 -69.8%
16.61
16,942,200 USD
1,020,000 -69.8% 16.61 16,942,200 USD
2023-08-04 2023-08-02
US ImmunoGen Inc (IMGN)
S Sale
8,636 -1.9%
18.15
156,743 USD
8,636 -1.9% 18.15 156,743 USD
2023-08-04 2023-08-02
US ImmunoGen Inc (IMGN)
S Sale
986,521 -68.7%
17.45
17,214,791 USD
986,521 -68.7% 17.45 17,214,791 USD
2020-02-25 2020-02-24
US ImmunoGen Inc (IMGN)
PS Planned sale
55,222 -11.3%
4.99
275,558 USD
55,222 -11.3% 4.99 275,558 USD
2019-02-25 2018-02-22
US ImmunoGen Inc (IMGN)
PS Planned sale
51,070 -9.5%
5.60
285,992 USD
51,070 -9.5% 5.60 285,992 USD